Lion Point Capital, LP
Source: SEC Form 13F · as of Mar 2026Lion Point Capital, LP holds 19 biotech & pharma companies tracked by BioSniper, totaling $9.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$9.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for MoonLake Immunotherapeutics (MLTX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MLTXMoonLake Immunotherapeutics | 67,500 | $1.3M |
| MISTMilestone Pharmaceuticals Inc. | 820,000 | $976K |
| GERNGERON CORP | 578,000 | $861K |
| ARDXARDELYX, INC. | 128,650 | $771K |
| FENCFENNEC PHARMACEUTICALS INC. | 112,434 | $691K |
| IRONDisc Medicine, Inc. | 8,100 | $518K |
| CUECue Biopharma, Inc. | 2,202,854 | $506K |
| CMPSCOMPASS Pathways plc | 80,000 | $442K |
| BHVNBiohaven Ltd. | 51,700 | $437K |
| JSPRJasper Therapeutics Inc. | 465,000 | $407K |
| HUMAHumacyte Inc. | 650,000 | $394K |
| KURAKura Oncology, Inc. | 46,000 | $374K |
| BBIOBridgeBio Pharma, Inc. | 5,000 | $371K |
| RCKTRocket Pharmaceuticals Inc. | 86,000 | $308K |
| QUREuniQure N.V. | 14,700 | $240K |
| RGNXREGENXBIO Inc. | 26,600 | $223K |
| INVAInnoviva, Inc. | 8,200 | $191K |
| GHRSGH Research PLC | 10,200 | $143K |
| ARQTArcutis Biotherapeutics, Inc. | 5,250 | $124K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.